Kirkland-based heart care company Cardiac Dimensions on Thursday raised a $53 million Series E round.
The U.S. Food and Drug Administration (FDA) has approved a new drug for a serious heart condition that affects thousands of ...
Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million ...
Researchers have developed a smartphone app that uses machine learning to accurately determine body composition—which is ...
Studies conducted in human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) compared various cassette configurations and informed the final design of TN-201, which incorporates a ...